Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:2.3.1.107 (DAT)
 1,471 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The WMS-R represents a significant improvement over the original version of the WMS. Patterns of performance on the five WMS-R indices successfully differentiated patients with a "cortical" (that is, DAT) from patients with a "subcortical" (that is, HD) dementia. The differences between ACI and GMI also indicated that DAT patients' attention and concentration were better preserved than those of equally demented HD patients. Analyses of the differences between GMI and DMI indicated that rapid forgetting was more apparent for DAT than for HD patients in the early stages of these disorders. When savings scores for the Logical Memory and Visual Reproduction tests were used to examine retention over a 30-minute period, both mildly and moderately demented DAT patients demonstrated more rapid forgetting than did HD patients with similar levels of cognitive decline. Discriminant analyses performed with these indices of forgetting showed 95 per cent accurate classification of DAT and elderly controls, and 79 per cent correct classification of DAT and HD patients. Assessment of the patients' tendencies to make prior-item intrusion errors on the Visual Reproduction tests of the WMS and WMS-R yielded significant differences between patient groups and the two versions of the test. Patients with DAT made significantly more prior-figure intrusion errors than did HD patients on both versions of the VRT, but the original WMS form of this figural memory test was more likely to elicit such errors than was the revised version. Despite many improvements in the revised scale, a number of limitations still exist including standardization and a lack of norms for elderly individuals, as well as failures to include tests of verbal recognition and adequate measures of nonverbal memory.
 ...
PMID:Differentiating Alzheimer's disease from Huntington's disease with the Wechsler Memory Scale-Revised. 252 59

Analysis of the discrepancy between memory and intellectual ability has received some support as a means for evaluating memory impairment. Recently, comprehensive base rate tables for General Ability Index (GAI) minus memory discrepancy scores (i.e., GAI-memory) were developed using the WAIS-III/WMS-III standardization sample (Lange, Chelune, & Tulsky, in press). The purpose of this study was to evaluate the clinical utility of GAI-memory discrepancy scores to identify memory impairment in 34 patients with Alzheimer's type dementia (DAT) versus a sample of 34 demographically matched healthy participants. On average, patients with DAT obtained significantly lower scores on all WAIS-III and WMS-III indexes and had larger GAI-memory discrepancy scores. Clinical outcome analyses revealed that GAI-memory scores were useful at identifying memory impairment in patients with DAT versus matched healthy participants. However, GAI-memory discrepancy scores failed to provide unique interpretive information beyond that which is gained from the memory indexes alone. Implications and future research directions are discussed.
 ...
PMID:Application of new WAIS-III/WMS-III discrepancy scores for evaluating memory functioning: relationship between intellectual and memory ability. 1662 86